The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
TCT 2021 | ESH CML/MPNs 2021: what to expect?
Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, discusses the upcoming 2nd How to Diagnose and Treat CML/MPN meeting, an international virtual European School of Hematology (ESH) meeting which will translate key updates in the treatment and management of chronic myeloid leukemia and myeloproliferative neoplasms. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.
